43 results
8-K/A
EX-99.2
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
with Vertex and the timing of such achievements, triggering the Company’s obligation to make applicable payments;
the hiring of additional clinical, scientific … is located. The Company also faces competition for the hiring of scientific and clinical personnel from universities and research institutions, many
8-K/A
EX-99.3
pxpzujmde9575zkknl
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.1
nqd504wwxp343g26
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
f2z047lwn8c i5blkyk2
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
wflwbdd dkwdtg3zr
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
i0klh
10 May 23
Registration of securities issued in business combination transactions
9:56pm
DEFA14A
EX-99.1
iebo0tzru
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
bt7ud6a0xv47oq5swv3
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
8-K
EX-1.1
y9sp4
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-99.1
jw415rzo8r 2aqe5vy
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm